Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASPH | Q12797 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29817020 | 1.00 | ASPH (0.46) | ASPHCES2MGLLKDM4EALDH1A1 | |
| SCHEMBL32678783 | 0.87 | ASPH (0.49) | ASPHCES2MGLLKDM4EALDH1A1 | |
| SCHEMBL32678781 | 0.87 | ASPH (0.49) | ASPHCES2MGLLKDM4EALDH1A1 | |
| SCHEMBL2555370 | 0.82 | CFTR (0.49) | CES2MGLLKDM4EALDH1A1HPGD | |
| SCHEMBL29700447 | 0.78 | MGLL (0.52) | MGLLRXRARXRB | |
| SCHEMBL918043 | 0.78 | ALDH1A1 (0.44) | MGLLKDM4EALDH1A1HSD17B10CYP2C19 | |
| SCHEMBL30807652 | 0.78 | ALDH1A1 (0.44) | MGLLKDM4EALDH1A1HSD17B10CYP2C19 | |
| SCHEMBL3789433 | 0.78 | MGLL (0.52) | MGLLRXRARXRB | |
| SCHEMBL362047 | 0.77 | CES2 (0.41) | ASPHCES2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL29689051 | 0.77 | CES2 (0.41) | ASPHCES2KDM4EALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250032533-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2025-01-30 | — | — | US | disclosed |
| US-12059432-B2 | Substituted phenyl boronic acid containing polymers and methods of use | GLYSCEND, INC. (US) | 2024-08-13 | — | — | US | disclosed |
| US-20240082297-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2024-03-14 | — | — | US | disclosed |
| US-20230338415-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2023-10-26 | — | — | US | disclosed |
| US-11576928-B2 | Substituted phenyl boronic acid containing polymers and methods of use | GLYSCEND, INC. (US) | 2023-02-14 | — | — | US | disclosed |
| US-11491183-B2 | Substituted phenyl boronic acid containing polymers and methods of use | GLYSCEND, INC. (US) | 2022-11-08 | — | — | US | disclosed |
| US-11491182-B2 | Substituted phenyl boronic acid containing polymers and methods of use | GLYSCEND, INC. (US) | 2022-11-08 | — | — | US | disclosed |
| US-11484548-B2 | Substituted phenyl boronic acid containing polymers and methods of use | GLYSCEND, INC. (US) | 2022-11-01 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-20220265703-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2022-08-25 | — | — | US | disclosed |
| US-20160272617-A1 | SUBSTITUTED PHENYLALANINE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-09-22 | — | — | US | disclosed |
| CN-105745192-A | Substituted phenylalanine derivatives | 拜耳制药股份公司 | 2016-07-06 | — | — | CN | disclosed |
| US-20150093291-A1 | COMPETITIVE BINDING DENDRIMER-BASED SYSTEM FOR ANALYTE DETECTION | RECEPTORS LLC (US) | 2015-04-02 | — | — | US | disclosed |
| CN-103038245-B | Modified c-3 betulinic acid derivatives as HIV maturation inhibitors | BRISTOL MYERS SQUIBB CO | 2015-03-25 | — | — | CN | disclosed |
| US-8754068-B2 | Modified C-3 betulinic acid derivatives as HIV maturation inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-06-17 | — | — | US | disclosed |
| EP-2576585-A1 | MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS | Bristol-Myers Squibb Company (US) | 2013-04-10 | — | — | EP | disclosed |
| CN-103038245-A | Modified c-3 betulinic acid derivatives as HIV maturation inhibitors | BRISTOL MYERS SQUIBB CO | 2013-04-10 | — | — | CN | disclosed |
| WO-2013025616-A1 | COMPETITIVE BINDING DENDRIMER-BASED SYSTEM FOR ANALYTE DETECTION | RECEPTORS LLC (US) | 2013-02-21 | — | — | WO | disclosed |
| US-20120142707-A1 | MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2012-06-07 | — | — | US | disclosed |
| WO-2011153315-A1 | MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11484548-B2 | Substituted phenyl boronic acid containing polymers and methods of use | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-11491182-B2 | Substituted phenyl boronic acid containing polymers and methods of use | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-20160272617-A1 | SUBSTITUTED PHENYLALANINE DERIVATIVES | PAH, PEPD, AADAT | ASPH 129/4885CES2 1828/4885MGLL 2185/4885 |
| US-20120142707-A1 | MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS | BET1, BIRC3, CYTH3 | ASPH 2700/4885CES2 722/4885MGLL 2629/4885 |
| US-20230338415-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-11576928-B2 | Substituted phenyl boronic acid containing polymers and methods of use | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-11491183-B2 | Substituted phenyl boronic acid containing polymers and methods of use | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-20250032533-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-20240082297-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-12059432-B2 | Substituted phenyl boronic acid containing polymers and methods of use | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
| US-20220265703-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | SLC10A2, PYGL, SLC10A1 | ASPH 654/4885CES2 483/4885MGLL 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.